3543 results for «2082»
3543 results
Complications in STEMI : dissections and more
21 May 2025 – From EuroPCR 2025
Address complications encountered in STEMI interventions such as dissections and coronary perforations. Learn from case presentations highlighting procedural challenges, management of delayed perforations, and balancing procedural perfection with practical outcomes.
OHCM, ablation complications: interventional solutions
21 May 2025 – From EuroPCR 2025
Explore interventional solutions for complications arising in obstructive hypertrophic cardiomyopathy (OHCM) and ablation procedures. Cases include complex congenital anomalies, novel non-invasive treatments, dual pulmonary vein stenosis, iatrogenic fistulas, and ablation-related cardiac defects.
Hotline TAVI 3: Challenging anatomical and clinical scenarios
22 May 2025 – From EuroPCR 2025
This hotline session presents challenging anatomical and clinical scenarios in TAVI, including outcomes in bicuspid aortic valve patients, chronic aortic regurgigation, comparisons of surgical versus percutaneous approaches, and real-world data on valve performance and resource utilization.
Inludes:
- Five-year outcomes from the Evolut low risk TAVR bicuspid study
- Surgical versus...
DCB PCI: are we ready for complex de novo lesions?
21 May 2025 – From EuroPCR 2025
Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent...
Cathlab harmony: building high-performance teams
21 May 2025 – From EuroPCR 2025
Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.
TAVI for aortic regurgitation: off-label use
21 May 2025 – From EuroPCR 2025
Explore the complexities and off-label challenges of transcatheter aortic valve implantation (TAVI) in patients with severe pure aortic regurgitation. This session highlights the bold strategies, complication management, and innovative use of the Octacor valve in this demanding clinical scenario, providing valuable insights into navigating a difficult...
DES and bioadaptator technologies in contemporary practice
21 May 2025 – From EuroPCR 2025
Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...
Large thrombus burden: contemporary solutions
21 May 2025 – From EuroPCR 2025
This session presents contemporary strategies for managing large thrombus burden in STEMI patients. Learn from expert cases demonstrating multiple effective approaches including modified manual thrombus aspiration guided by intravascular ultrasound (IVUS) and streamlined primary PCI techniques, essential for optimizing outcomes in complex thrombotic scenarios.
Management of non-culprit lesions in patients with ACS and multivessel disease
21 May 2025 – From EuroPCR 2025
This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...
DCB in challenging scenarios - Part 1
21 May 2025 – From EuroPCR 2025
Discover the expanding role of drug-coated balloons (DCB) in challenging coronary interventions. This session covers their application in acute coronary syndrome complications, complex coronary artery disease revascularization, and in-stent restenosis at left main bifurcations, highlighting innovative combinations with drug-eluting stents for managing complex bifurcation and trifurcation...
CTO, modern challenges and solutions
21 May 2025 – From EuroPCR 2025
Address modern challenges in chronic total occlusion (CTO) interventions with this session focusing on the latest technologies and techniques. Learn key procedural strategies and best practices through detailed case studies, and understand how evolving technology is shaping the future of CTO revascularization.
Interventional approaches for cardiogenic shock
21 May 2025 – From EuroPCR 2025
Gain comprehensive insights into interventional strategies for cardiogenic shock, including management of non-ischemic etiologies, innovative use of ventricular vents with ECMO, the interplay of Impella, PCI, and MitraClip, and bridging techniques using left atrial veno-arterial ECMO in severe valve disease and biventricular failure.
High-risk plaque assessment with intracoronary imaging
21 May 2025 – From EuroPCR 2025
Explore high-risk plaque assessment using intracoronary imaging modalities such as OCT and AI-driven analysis. This session investigates associations between thin-cap fibroatheroma, local inflammation, and adverse outcomes, highlighting novel biomarkers and imaging techniques that enhance prognostic evaluation and guide personalized coronary artery disease management.
The many faces of TTVR
21 May 2025 – From EuroPCR 2025
Discover the diverse clinical scenarios of transcatheter tricuspid valve replacement (TTVR). This session presents complex cases including acute right ventricular afterload mismatch, combined pulmonary and tricuspid valve interventions in carcinoid heart disease, and challenges in dilated cava anatomy, showcasing the expanding frontiers of TTVR therapy.
Impact of imaging in treatment of bifurcation lesions - Part 2
21 May 2025 – From EuroPCR 2025
Focus on the impact of advanced imaging in treating bifurcation lesions with this session. It covers the use of IVUS and OCT to optimize side branch protection, manage complex lesions in elderly symptomatic patients, and elucidate nuanced techniques such as the Szabo method, providing critical guidance...
Paravalvular and defects percutaneous closure
21 May 2025 – From EuroPCR 2025
This session presents percutaneous closure techniques for paravalvular leaks and cardiac defects, highlighting complex cases such as closure in patients with mechanical prostheses, pseudoaneurysms, and post-redo sternotomy challenges. Gain practical knowledge on device selection and procedural strategies for successful leak and defect management.
Complex multivessel disease - LIVE Case
21 May 2025 – From EuroPCR 2025
An 89-year-old male patient presented with stable angina, preserved LV function and some risk factors such as hypertension and diabetes. CT scan and angiography revealed occlusion of proximal RCA and bifurcation lesions on LAD and circumflex (medina 1,1,1). Operators treated the bifurcation lesions with provisional stenting.
Regarding...
Which valve is best for my patient?
21 May 2025 – From EuroPCR 2025
This session guides clinicians in selecting the most appropriate transcatheter aortic valve tailored to individual patient characteristics. Through diverse case discussions, including patients with coronary artery disease, small anatomies, bicuspid valves, and surgical bioprostheses, it elucidates decision-making processes and planning for complex TAVI anatomies.
Current DCB practice: from lesion preparation to follow-up
21 May 2025 – From EuroPCR 2025
Explore current best practices in drug-coated balloon (DCB) angioplasty from lesion preparation to follow-up. This session discusses common indications, management of dissections and complications, and shares practical tips and case examples, equipping clinicians with comprehensive knowledge to optimize DCB use in contemporary PCI.
TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3
21 May 2025 – From EuroPCR 2025
Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.
